ES469225A1 - Procedimiento para potenciar la accion de las vacunas. - Google Patents

Procedimiento para potenciar la accion de las vacunas.

Info

Publication number
ES469225A1
ES469225A1 ES469225A ES469225A ES469225A1 ES 469225 A1 ES469225 A1 ES 469225A1 ES 469225 A ES469225 A ES 469225A ES 469225 A ES469225 A ES 469225A ES 469225 A1 ES469225 A1 ES 469225A1
Authority
ES
Spain
Prior art keywords
potentiated
vaccines
acellular vaccines
polysaccharide capsules
acellular
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES469225A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pierre Fabre SA
Original Assignee
Pierre Fabre SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre SA filed Critical Pierre Fabre SA
Publication of ES469225A1 publication Critical patent/ES469225A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0266—Klebsiella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ES469225A 1977-04-29 1978-04-27 Procedimiento para potenciar la accion de las vacunas. Expired ES469225A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7713009A FR2388563A1 (fr) 1977-04-29 1977-04-29 Vaccins acellulaires perfectionnes contenant des polysaccharides capsulaires

Publications (1)

Publication Number Publication Date
ES469225A1 true ES469225A1 (es) 1978-11-16

Family

ID=9190107

Family Applications (1)

Application Number Title Priority Date Filing Date
ES469225A Expired ES469225A1 (es) 1977-04-29 1978-04-27 Procedimiento para potenciar la accion de las vacunas.

Country Status (10)

Country Link
JP (1) JPS53136516A (enrdf_load_stackoverflow)
BE (1) BE866464A (enrdf_load_stackoverflow)
CA (1) CA1103155A (enrdf_load_stackoverflow)
CH (1) CH630806A5 (enrdf_load_stackoverflow)
DE (1) DE2818922A1 (enrdf_load_stackoverflow)
ES (1) ES469225A1 (enrdf_load_stackoverflow)
FR (1) FR2388563A1 (enrdf_load_stackoverflow)
GB (1) GB1603340A (enrdf_load_stackoverflow)
IT (1) IT1156717B (enrdf_load_stackoverflow)
NL (1) NL7804660A (enrdf_load_stackoverflow)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1115210A (en) * 1977-11-28 1981-12-29 Dennis J. Carlo Pneumococcal vaccine
US4324887A (en) * 1978-08-16 1982-04-13 President And Fellows Of Harvard College Type II group B Streptococci polysaccharide
FR2444464A1 (fr) * 1978-12-19 1980-07-18 Fabre Sa Pierre Proteoglycanes bacteriens purifies, procede pour leur preparation et vaccin les contenant
US4242501A (en) * 1979-08-08 1980-12-30 American Cyanamid Company Purification of pneumococcal capsular polysaccharides
US4287173A (en) * 1979-09-24 1981-09-01 Merck & Co., Inc. Vaccine for dental caries
FR2471785A1 (fr) 1979-12-21 1981-06-26 Fabre Sa Pierre Preparations immunostimulantes a base d'arn ribosomaux et procede de preparation des arn
FR2475900A1 (fr) * 1980-02-20 1981-08-21 Fabre Sa Pierre Complexe vaccinal contenant un antigene specifique et vaccin le contenant
FR2495939B1 (fr) * 1980-12-11 1985-10-11 Merieux Inst Procede de purification de polyosides de streptococcus pneumoniae et vaccin a base de polyosides ainsi purifies
BE889979A (fr) * 1981-08-14 1982-02-15 Smith Kline Rit Procede de preparation de polysaccharides bacteriens capsulaires antigeniques purifies, produits obtenus et leur utilisation
GB8906795D0 (en) * 1989-03-23 1989-05-10 Carroll Noel Method of preparing vaccines
DE4141970C2 (de) * 1991-12-16 1998-02-19 Charite Med Fakultaet Kombinationsimpfstoff gegen AIDS, Bilharziose und Tuberkulose und Verfahren zu seiner Herstellung
JPH0651347U (ja) * 1992-12-21 1994-07-12 有限会社河上建築事務所 軒樋の枯葉止め
FR2703252B1 (fr) * 1993-03-31 1996-09-06 Fernand Narbey Torossian Complexe immunomodulateur anti SIDA.
JP3990455B2 (ja) * 1996-02-14 2007-10-10 メルク エンド カンパニー インコーポレーテッド 多糖沈殿法
US6410025B1 (en) 1996-02-14 2002-06-25 Merck & Co., Inc. Polysaccharide precipitation process
FR2790961B1 (fr) * 1999-03-17 2001-06-22 Fabre Pierre Sante Utilisation d'une composition comprenant des proteoglycanes de klebsiella pneumoniae, et des ribosomes ou des arn ribosomaux bacteriens pour le traitement et/ou la prevention des maladies parodontales

Also Published As

Publication number Publication date
DE2818922A1 (de) 1978-11-09
BE866464A (fr) 1978-10-27
FR2388563B1 (enrdf_load_stackoverflow) 1981-01-09
NL7804660A (nl) 1978-10-31
CA1103155A (fr) 1981-06-16
IT7849126A0 (it) 1978-04-28
IT1156717B (it) 1987-02-04
CH630806A5 (en) 1982-07-15
FR2388563A1 (fr) 1978-11-24
JPS53136516A (en) 1978-11-29
GB1603340A (en) 1981-11-25

Similar Documents

Publication Publication Date Title
ES469225A1 (es) Procedimiento para potenciar la accion de las vacunas.
JPS5461112A (en) Oncostatic polysaccharide* its preparation* and oncostatic drugs containing it as an effective component
EP0024493A3 (en) Pneumococcal capsular polysaccharide, preparation thereof, multivalent pneumococcal vaccine and method of inducing active immunity
DE3361598D1 (en) Process for the preparation of polysaccharide-protein complexes from bacterial envelopes, products obtained and immunogenic compostions containing them
MX9203458A (es) Segmentos inmunogenicos que contienen glicoproteinas quimericas de las glicoproteinas de virus sincitial respiratorio humano.
PT70610A (fr) Procede de preparation de proteoglycanes bacteriens destines a etre incorpores avec un vaccin et vaccin qui les contient
GT197854594A (es) Vacuna contra haemophilus influenzae
ZA784324B (en) High molecular weight meningococcal group c vaccine and method for preparation thereof
ES466359A1 (es) Procedimiento para preparar vacunas vivas e inactivas del virus de la rabia.
AU6383296A (en) Multivalent bovine coronavirus vaccine and method of treating bovine coronavirus infection
PH12022550939A1 (en) Chikungunya virus-like particle vaccine and methods of using the same
ES449941A1 (es) Un metodo de preparacion de un nuevo virus vivo de la rabia.
PL355012A1 (en) Vaccine
EP0090660A3 (en) Neisseria gonorrhoeae vaccine
ES476703A1 (es) Procedimiento para preparar una heterovacuna para el trata -miento terapeutico del sindrome de los triconomas.
HUP9700975A2 (hu) Élő, legyengített, Pasteurellaceae családba tartozó, RTX-termelő baktériumok
JPS5543041A (en) Immunity raising agent
FR2047886A1 (en) Non-toxic anti-whooping cough vaccine
GB777018A (en) Poliomyelitis vaccine products and methods for preparing the same
EP0309898A3 (en) Method for the induction of a cytotoxic t cell response
CS189587B2 (en) Method of preparing viruses strains which stimulate natural defensive ability of microorganisms without contemporary action as antigen
BE842814A (fr) Compositions antigeniques, leur procede de preparation et leur application comme vaccins
JPS53109925A (en) Preparation of anti-tumor polysaccharides
JPS53109924A (en) Preparation of anti-tumor polysaccharides
JPS5394021A (en) Preparation of anti-tumor polysaccharide